ネットワークの混乱分析による作用の複合メカニズムの解明
Jung Hoon Woo1, Yishai Shimoni2, Wan Seok Yang3
1Department of Biomedical Informatics (DBMI), Columbia University, New York, NY 10032, USA.
Cell
|July 18, 2015
まとめ
この研究は,小分子に対する作用機構 (MoA) を特定するための新しいネットワークベースのアプローチを提示しています. この方法は化合物の標的と相互作用を効率的に明らかにし,薬物の発見と毒性の評価を助けます.
科学分野:
- 薬理学について
- システム生物学
- コンピュータ生物学
背景:
- 小分子化合物の作用機構 (MoA) を特定することは,薬剤の有効性および毒性の評価に極めて重要です.
- 現在の方法はしばしば労働集約的で,主に高親密性のタンパク質ターゲットに焦点を当てています.
- ゲノム全体のMoAの包括的な理解は,薬の開発において重要な課題であり続けています.
研究 の 目的:
- ゲノム全体のMoA解明のための新しい規制ネットワークベースのアプローチを開発し,検証する.
- 化合物MoAに関与する既知のタンパク質と新しいタンパク質を識別する.
- 未知のMoAを持つ薬の予想外の化合物の類似性とメカニズムを明らかにする.
主な方法:
- 化合物の乱射後のグローバル分子相互作用の乱射を分析する規制ネットワークベースのアプローチを使用した.
- 分子ネットワークへの複合効果を評価するために,細胞の乱れプロフィールを適用した.
- 解明された新しいMoAタンパク質の実験的検証を行った.
主要な成果:
- ネットワークベースのアプローチは,試験された化合物の70%で確立されたMoAタンパク質を成功裏に特定しました.
- 新しいMoAタンパク質が解明され,その後実験的に検証された.
- アルトレタミンは抗がん剤で,グルタチオン過酸化酵素4のリピッド修復活性阻害剤として特定され,スルファサラジンとの類似性を明らかにした.
結論:
- 規制ネットワーク分析は,小分子MoAを全ゲノムで解明するための強力なツールを提供します.
- このアプローチは新しい薬の標的とメカニズムを明らかにし,薬の発見と開発を向上させることができます.
- 予想外の複合的な類似点と再利用の機会を 特定する可能性を強調しています
さらに関連する動画
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.9K
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
727
関連する概念動画
01:21Mechanistic Models: Overview of Compartment Models
536
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
536
01:14Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
101
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
101
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
3.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
3.0K
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
117
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
117
01:27Pharmacodynamic Models: Overview
91
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
91
01:26Targets for Drug Action: Overview
11.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.5K